C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
11/2009
11/25/2009	EP2121591A2 Ppar active compounds
11/25/2009	EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009	EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009	EP1765335B1 Pyrazole amide derivatives, compositions containing such compounds and methods of use
11/25/2009	EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009	CN101589027A Process for the sulfinylation of a pyrazole derivative
11/25/2009	CN101585811A Pyrazole carbamate genus compound containing alkynes aryl as well as preparation method and application thereof
11/25/2009	CN101585810A Preparation method of 5-(4-chlorphenyl)-1-(2, 4-dichlorophenyl) 4- methylpyrazole-3-formic ether
11/25/2009	CN101585806A Azo comounds or their salt and process for producing the same
11/25/2009	CN101584691A Compounds effecting glucokinase
11/24/2009	US7622595 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
11/24/2009	US7622493 Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
11/24/2009	US7622492 antidiabetic agents; (4S,7R)-1-Benzyl-7,8,8-trimethyl-2-phenyl-1,2,4,5,6,7-hexahydro-4,7-methano-indazol-3-one; treating metabolic disorder comprises diabetes, obesity or metabolic syndrome, type II diabetes
11/24/2009	US7622491 Modulators of PPAR and methods of their preparation
11/24/2009	US7622471 Pyrazole derivatives having a pyridazine and pyridine functionality
11/24/2009	US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/24/2009	CA2385882C Tyrosine derivatives
11/19/2009	WO2009140624A2 Glucokinase activators
11/19/2009	WO2009140451A1 Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof
11/19/2009	WO2009140342A1 Glucagon receptor antagonists, compositions, and methods for their use
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139340A1 Pyrazole compound
11/19/2009	WO2009138440A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009	WO2009138375A1 Process for the preparation of amides
11/19/2009	WO2009077390A3 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 4,5 diaminopyrazole, and hair dyeing process using these dyes or precursors
11/19/2009	US20090286976 One-pot synthesis of fluorinated ionic liquids
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286835 Novel compounds
11/19/2009	US20090286791 Amide Compounds
11/19/2009	US20090286784 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/19/2009	US20090286758 Substituted n-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/19/2009	US20090286683 Benzoylpyrazole compounds and herbicides containing them
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	US20090282622 oxidation color dyes 4,5-diaminopyrazole derivatives; hair dyes; developers
11/19/2009	CA2724294A1 Glucagon receptor antagonists, compositions, and methods for their use
11/19/2009	CA2724215A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009	CA2724116A1 Glucokinase activators
11/19/2009	CA2724077A1 Amide compound
11/19/2009	CA2724065A1 Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof
11/18/2009	EP2118069A2 Bis-aryl amide derivatives useful for the treatment of cancer
11/18/2009	EP2118068A1 Indazoles used to treat estrogen receptor beta mediated disorders
11/18/2009	EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009	EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009	EP2018367B1 Novel microbiocides
11/18/2009	EP1506261B1 Trisazo dyes for ink jet printing
11/18/2009	EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009	EP1370525B1 Biguanide derivatives
11/18/2009	CN101583622A Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
11/18/2009	CN101583611A Inhibitors of hepatitis C virus
11/18/2009	CN101583602A Process for the sulfinylation of a pyrazole derivative
11/18/2009	CN101583596A N-substituted-azacyclylamines as histamine-3 antagonists
11/18/2009	CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/18/2009	CN101583276A Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
11/18/2009	CN101580492A Method for preparing antiseptic triaryl-2-pyrazoline derivative by microwave
11/18/2009	CN101580491A Microwave synthesis method of antiseptic triaryl-2-pyrazoline derivative
11/18/2009	CN100560570C Method of synthesizing 5-(4-chloro-phenyl)-N-hydroxy-1-(4-methoxy-phenyl)-N-methyl-1H-pyrazole-3-propionamide
11/17/2009	US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009	US7618971 Mitotic kinesin inhibitors
11/17/2009	CA2407094C Diazabicyclic central nervous system active agents
11/17/2009	CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009	CA2382296C Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
11/17/2009	CA2259583C Azolo triazines and pyrimidines
11/12/2009	WO2009137651A2 Fungicidal substituted azoles
11/12/2009	WO2009137538A2 Fungicidal substituted azoles
11/12/2009	WO2009137339A2 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	WO2009137338A1 Pyrazole compounds as ccr1 antagonists
11/12/2009	WO2009135944A1 Trisubstituted pyrazoles as acetylcholine receptor modulators
11/12/2009	WO2009135860A1 Method for manufacturing aryl carboxamides
11/12/2009	WO2009135808A2 Method for preparing 1,3,4-substituted pyrazol compounds
11/12/2009	WO2009135526A1 Alpha-mercapto-amides
11/12/2009	WO2008152525A3 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them.
11/12/2009	US20090281328 Pdk-1/akt signaling inhibitors
11/12/2009	US20090281131 Diebenzofuran derivatives as inhibitors of pde-4 and pde-10
11/12/2009	US20090281102 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	CA2725446A1 Method for preparing 1,3,4-substituted pyrazol compounds
11/12/2009	CA2723893A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	CA2723550A1 Alpha-mercapto-amides
11/12/2009	CA2722811A1 Pyrazole compounds as ccr1 antagonists
11/12/2009	CA2722805A1 Trisubstituted pyrazoles as acetylcholine receptor modulators
11/12/2009	CA2721695A1 Method for manufacturing aryl carboxamides
11/11/2009	EP2116539A1 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
11/11/2009	EP2116535A1 Glucokinase-activating substance
11/11/2009	EP2116533A1 Glucokinase activator
11/11/2009	EP2114894A1 Heterocyclyl-substituted-ehylamino-phenyl derivatives, their preparation and use as medicaments
11/11/2009	EP2114893A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
11/11/2009	EP2114892A1 Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments
11/11/2009	EP2114891A1 Substituted pyrazoline compounds with acat inhibition activity
11/11/2009	EP1742908B1 Non-nucleoside reverse transcriptase inhibitors
11/11/2009	EP1492487B1 Mitotic kinesin inhibitors
11/11/2009	CN101578270A Process for the sulfinylation of a pyrazole derivative
11/11/2009	CN101578269A N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g.
11/11/2009	CN101578263A Sulfonamides and their use as a medicament
11/11/2009	CN101578261A Heteroaryl-substituted serine amides
11/11/2009	CN101578260A Insecticidal compounds
11/11/2009	CN101578257A Process for production of hydroxyadamantaneamine
11/11/2009	CN100558710C Iodopyrazolyl carboxanilides.
11/11/2009	CN100558428C Calcitonin gene related peptide receptor antagonists
11/11/2009	CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/10/2009	US7615572 Pyrrole and pyrazole DAAO inhibitors
11/10/2009	US7615563 Compositions useful as inhibitors of voltage-gated sodium channels

1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 256